Global biometrics CROS NT operates as a global biometrics service provider with 28+ years in business, offering data-driven solutions for clinical and observational trials. This positions the company as a mature partner for sponsors seeking experienced biometric services across Europe and the US.

Acquisition footprint As part of Alira Health, CROS NT benefits from a broader healthcare and life sciences network, suggesting cross-sell opportunities into advisory services and potential integration with Alira Health’s client base.

Diverse therapeutic exposure With experience in over 20 therapeutic areas and 100 indications across 14 countries, CROS NT can tailor biometrics for varied trials, enabling targeted outreach to sponsors with niche or multi-therapeutic programs.

Mid-market sweet spot Revenue is in the $10M-$25M range with a small-to-mid employee base, indicating a nimble, cost-efficient partner ideal for mid-sized trials or as a flexible biometrics extension for larger sponsors.

Expansion catalysts Historical partnerships and leadership additions (COO hire, global expansion initiatives, past takeovers) signal a growth trajectory and readiness to scale services, presenting opportunities for new operating model discussions and expanded scope.